157 followers 53 článků/týdně
Struggling AlloVir finds new identity by merging into eye disease biotech

Struggling AlloVir finds new identity by merging into eye disease biotech jwaldron Fri, 11/08/2024 - 08:04

Fri Nov 8, 2024 17:02
Dynavax drops Tdap vaccine after considering phase 1 data, competition

Dynavax drops Tdap vaccine after considering phase 1 data, competition jwaldron Fri, 11/08/2024 - 05:44

Fri Nov 8, 2024 17:02
Dig into this year’s Fierce Biotech Graveyard, layoff numbers

Dig into this year’s Fierce Biotech Graveyard, layoff numbers aellison Tue, 11/05/2024 - 16:01

Fri Nov 8, 2024 17:02
Nkarta continues pivot to autoimmune by shelving lymphoma program for CAR NK candidate

Nkarta continues pivot to autoimmune by shelving lymphoma program for CAR NK candidate jwaldron Fri, 11/08/2024 - 04:56

Fri Nov 8, 2024 16:01
Chutes & Ladders—Trevena teeters on edge with C-suite shakedown

Chutes & Ladders—Trevena teeters on edge with C-suite shakedown dincorvaia Thu, 11/07/2024 - 15:37

Fri Nov 8, 2024 16:01
Carisma's Moderna-powered in vivo macrophage cell therapy shrinks lung and liver tumors in mice

Carisma's Moderna-powered in vivo macrophage cell therapy shrinks lung and liver tumors in mice dincorvaia Thu, 11/07/2024 - 13:07

Fri Nov 8, 2024 15:02

Vytvořte si vlastní zdroj

Jste připraveni to vyzkoušet?
Spusťte 14denní zkušební verzi bez nutnosti platební karty.

Vytvořit účet